Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Study suspended due to company decision prior to enrollment.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will examine the epidemiology (incidence and control of a disease), burden, clinical need, and treatment patterns of spasticity in patients with a diagnosis of Cerebral Palsy (CP), Multiple Sclerosis (MS), Stroke, Spinal Cord Injury (SCI), or Traumatic Brain Injury (TBI).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| All Participants | Patients with a diagnosis of CP, MS, Stroke, SCI, or TBI will be evaluated for spasticity by their healthcare provider. Patients diagnosed with spasticity requiring treatment will be enrolled in the study. There is no intervention administered in this study. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No Intervention | Other | There is no intervention administered in this study. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Investigator Assessment of Spasticity Severity using a 5-Point Scale | Day 1 | |
| Percentage of Participants with Spasticity not Receiving Treatment | Day 1 | |
| Spasticity Symptom Assessment Score using a 21-item Questionnaire | Day 1 | |
| Spasticity Impact Assessment Score using a 32-item Questionnaire | Day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of Participants with Spasticity Receiving Treatment | Day 1 | |
| Referral Patterns for Spasticity Management | Day 1 | |
| Spasticity Screening Tool Score using a 13-item Questionnaire |
Not provided
Inclusion Criteria:
-Diagnosis of Cerebral Palsy (CP), Multiple Sclerosis (MS), Stroke, Spinal Cord Injury (SCI), or Traumatic Brain Injury (TBI) for a minimum of 3 months
Exclusion Criteria:
-Participation in a spasticity clinical trial in the past 5 years.
Not provided
Not provided
Not provided
Patients with a diagnosis of CP, MS, Stroke, SCI, or TBI in clinical practice evaluated for spasticity.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Medical Director | Allergan | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Toms River | New Jersey | United States |
Not provided
| ID | Term |
|---|---|
| D009128 | Muscle Spasticity |
| ID | Term |
|---|---|
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D009122 | Muscle Hypertonia |
| D020879 | Neuromuscular Manifestations |
Not provided
Not provided
Not provided
Not provided
Not provided
| Day 1 |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |